News

Researchers found that cumulative exposure to disadvantaged neighborhoods predicted faster epigenetic aging across three biological clocks. Emotional distress, particularly anxiety, mediated part of this effect.

Researchers have developed a device that cuts protein sample consumption by as much as 97% while still producing high-quality structural data.

New research has found that inhibiting a protein called PTP1B improves learning and memory in a mouse model of Alzheimer's.

Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk patients already on statins. The pill could expand cholesterol treatment access if FDA approval leads to widespread adoption.

Researchers have mapped lung cancer "neighborhoods", finding that cell metabolism is key for determining immunotherapy response.

Researchers showed that in C. elegans, the protein MBD-2 regulates genes through repressive histone marks rather than DNA methylation. This alternative epigenetic mechanism preserves gene control despite evolutionary loss of 5mC.

Researchers found that a protein called CUL5 helps neurons eliminate tau, reducing their vulnerability to neurodegeneration.

Researchers discovered a bacterial protein that detects phage infection and forms membrane pores to kill the host cell before viruses replicate. Structural studies showed Rip1 binds phage proteins and assembles into rings that rupture membranes.

New research into how tau tangles form and spread paves the way toward a neuronal vaccine that stops neurodegeneration before it can spread.

UQ researchers have opened a "window to the brain" with a new diagnostic device that can determine how deadly brain tumours respond to treatment from a simple blood test.